These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 1748053)

  • 1. Renal factors influencing blood pressure threshold and choice of treatment for hypertension in IDDM.
    Mogensen CE; Hansen KW; Pedersen MM; Christensen CK
    Diabetes Care; 1991 Nov; 14 Suppl 4():13-26. PubMed ID: 1748053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of cilazapril and amlodipine on kidney function in hypertensive NIDDM patients.
    Velussi M; Brocco E; Frigato F; Zolli M; Muollo B; Maioli M; Carraro A; Tonolo G; Fresu P; Cernigoi AM; Fioretto P; Nosadini R
    Diabetes; 1996 Feb; 45(2):216-22. PubMed ID: 8549868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal functional reserve in IDDM patients.
    Sackmann H; Tran-Van T; Tack I; Hanaire-Broutin H; Tauber JP; Ader JL
    Diabetologia; 1998 Jan; 41(1):86-93. PubMed ID: 9498635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glomerular dysfunction in diabetic nephropathy.
    Zucchelli P; Zuccalà A; Sturani A
    Postgrad Med J; 1988; 64 Suppl 3():22-30; discussion 48-9. PubMed ID: 3074295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated ambulatory blood pressure in microalbuminuric IDDM patients is inversely associated with renal plasma flow. A compensatory mechanism?
    Poulsen PL; Juhl B; Ebbehøj E; Klein F; Christiansen C; Mogensen CE
    Diabetes Care; 1997 Mar; 20(3):429-32. PubMed ID: 9051400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diabetic renal disease: the quest for normotension--and beyond.
    Mogensen CE
    Diabet Med; 1995 Sep; 12(9):756-69. PubMed ID: 8542735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of blood pressure and antihypertensive treatment on incipient and overt nephropathy, retinopathy, and endothelial permeability in diabetes mellitus.
    Parving HH
    Diabetes Care; 1991 Mar; 14(3):260-9. PubMed ID: 2044441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BP and Renal Outcomes in Diabetic Kidney Disease: The Veterans Affairs Nephropathy in Diabetes Trial.
    Leehey DJ; Zhang JH; Emanuele NV; Whaley-Connell A; Palevsky PM; Reilly RF; Guarino P; Fried LF;
    Clin J Am Soc Nephrol; 2015 Dec; 10(12):2159-69. PubMed ID: 26482258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arterial hypertension and microalbuminuria in IDDM: the Italian Microalbuminuria Study.
    Mangili R; Deferrari G; Di Mario U; Giampietro O; Navalesi R; Nosadini R; Rigamonti G; Spezia R; Crepaldi G
    Diabetologia; 1994 Oct; 37(10):1015-24. PubMed ID: 7851680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monitoring diabetic nephropathy: glomerular filtration rate and abnormal albuminuria in diabetic renal disease--reproducibility, progression, and efficacy of antihypertensive intervention.
    Mogensen CE; Hansen KW; Nielsen S; Pedersen MM; Rehling M; Schmitz A
    Am J Kidney Dis; 1993 Jul; 22(1):174-87. PubMed ID: 8322781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences between nisoldipine and lisinopril on glomerular filtration rates and albuminuria in hypertensive IDDM patients with diabetic nephropathy during the first year of treatment.
    Rossing P; Tarnow L; Boelskifte S; Jensen BR; Nielsen FS; Parving HH
    Diabetes; 1997 Mar; 46(3):481-7. PubMed ID: 9032106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal protection and antihypertensive drugs: current status.
    Salvetti A; Mattei P; Sudano I
    Drugs; 1999 May; 57(5):665-93. PubMed ID: 10353294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Risk and prevention of diabetic nephropathy].
    Ravera M; Re M; Deferrari G
    G Ital Nefrol; 2007; 24 Suppl 38():13-9. PubMed ID: 17922442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stable glomerular filtration rate in normotensive IDDM patients with stable microalbuminuria. A 5-year prospective study.
    Mathiesen ER; Feldt-Rasmussen B; Hommel E; Deckert T; Parving HH
    Diabetes Care; 1997 Mar; 20(3):286-9. PubMed ID: 9051373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Norepinephrine-induced blood pressure rise and renal vasoconstriction are not attenuated by enalapril treatment in microalbuminuric IDDM.
    Hoogenberg K; Navis G; Dullaart RP
    Nephrol Dial Transplant; 1998 Mar; 13(3):640-5. PubMed ID: 9550640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diabetic nephropathy: from micro- to macroalbuminuria.
    Deferrari G; Repetto M; Calvi C; Ciabattoni M; Rossi C; Robaudo C
    Nephrol Dial Transplant; 1998; 13 Suppl 8():11-5. PubMed ID: 9870419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exogenous norepinephrine induces an enhanced microproteinuric response in microalbuminuric insulin-dependent diabetes mellitus.
    Hoogenberg K; Sluiter WJ; Navis G; Van Haeften TW; Smit AJ; Reitsma WD; Dullaart RP
    J Am Soc Nephrol; 1998 Apr; 9(4):643-54. PubMed ID: 9555667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Value of blood pressure self-monitoring as a predictor of progression of diabetic nephropathy.
    Rave K; Bender R; Heise T; Sawicki PT
    J Hypertens; 1999 May; 17(5):597-601. PubMed ID: 10403602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blood pressure lowering for the prevention and treatment of diabetic kidney disease.
    Thomas MC; Atkins RC
    Drugs; 2006; 66(17):2213-34. PubMed ID: 17137404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced responsiveness of blood pressure to sodium intake and to angiotensin II is associated with insulin resistance in IDDM patients with microalbuminuria.
    Trevisan R; Bruttomesso D; Vedovato M; Brocco S; Pianta A; Mazzon C; Girardi C; Jori E; Semplicini A; Tiengo A; Del Prato S
    Diabetes; 1998 Aug; 47(8):1347-53. PubMed ID: 9703338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.